jumble
发表于 2025-3-28 16:52:40
Cliff A. Robb,Russell N. James IIIample ocular and cutaneous TB, and the spectrum of clinical manifestations are described which should prompt a clinician to investigate further. Atypical infection in those with underlying immunosuppression is also explored within this chapter.
陶器
发表于 2025-3-28 22:24:35
http://reply.papertrans.cn/32/3156/315551/315551_42.png
photophobia
发表于 2025-3-29 00:19:51
Tuberculosis Infection Controlevidence guidance is provided as to define the need and requirement for hospital admission and discharge..The chapter includes a ‘questions and answers’ section taking advantages from a recent consensus document of experts published by the WHO European Region..Furthermore, the chapter proposes an exercise for self-learning.
glomeruli
发表于 2025-3-29 06:02:37
http://reply.papertrans.cn/32/3156/315551/315551_44.png
Serenity
发表于 2025-3-29 11:16:52
Treatment of Drug-Susceptible Tuberculosiside (Z), Ethambutol (E)]. In this chapter, recommendations regarding drug sensitive TB regimens are described, including recommendations about dosage, duration of treatent, and treatment on special situations.
Evocative
发表于 2025-3-29 13:04:28
http://reply.papertrans.cn/32/3156/315551/315551_46.png
书法
发表于 2025-3-29 17:52:01
http://reply.papertrans.cn/32/3156/315551/315551_47.png
他姓手中拿着
发表于 2025-3-29 21:07:29
Pathogenesis and Immunology of Tuberculosise released from diseased persons, typically through sneezing or coughing. The World Health Organization (WHO) in 2018 estimated 10 million new TB cases worldwide that led to 1.5 million deaths, thus ranking TB as the main cause of mortality from a single pathogen. In this chapter, we briefly describ
epinephrine
发表于 2025-3-30 01:13:45
http://reply.papertrans.cn/32/3156/315551/315551_49.png
set598
发表于 2025-3-30 06:48:41
Tuberculosis: WHO-Recommended Strategies and Global Health Perspectivesctoral strategy needs to be urgently funded and implemented. In this chapter we provide an overview of the principles, pillars, and main indicators of the World Health Organization (WHO)’s End TB Strategy, which is intended to serve as a comprehensive framework for countries to achieve the ambitious